Table of Content

Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary

Chapter 2 Market Overview
Overview
Types of GPCRs
Introduction of GPCR Cellular Responses
Importance of GPCRs in Disease Physiology
Regulatory Aspect

Chapter 3 Market Dynamics
Overview
Market Drivers
Rising Incidence of Chronic Diseases
Growing Demand for GPCR Drugs
Technological Advances in GPCR Research
Market Restraints
Challenges of Drug Discovery
Limitations of GPCR Structural Studies
Market Opportunities
Personalized Cancer Therapy

Chapter 4 Emerging Technologies and Developments
Overview
Emerging Technologies
Novel Screening Technology
Structural Analysis in GPCR-Targeted Drug Discovery
Experimental Screening in GPCR-Targeted Drug Discovery
Patent Analysis
Patent Review, by Applicant

Chapter 5 Market Segmentation Analysis
Market Overview
Segmentation Breakdown
GPCR-Targeting: Technologies and Global Markets
Market Analysis by Assay Type
cAMP Assays and cGMP Assays
Calcium Functional Assays
Arrestin Functional Assays
Radioligand-Binding and GTPgammaS Functional Assays
Reporter Gene Assays
Other Assays
Market Analysis by Product Type
Cell Lines
Detection Kits
Cell Culture Reagents
Ligands
Market Analysis by Application
Oncology/Cancers
Cardiovascular Diseases
Central Nervous System Diseases
Respiratory Diseases
Other Diseases
Geographic Breakdown
Market Analysis by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 6 Competitive Intelligence
Overview
Ranking of Companies in the Industry
Venture Fundings in the Industry

Chapter 7 Sustainability in the GPCR-Targeting Technologies Industry: An ESG Perspective
Sustainability in the Global GPCR Industry
ESG Risks and Ratings: Understanding the Data

Chapter 8 Appendix
Sources
Abbreviations
Company Profiles
AGILENT TECHNOLOGIES INC.
BD
DANAHER CORP.
ENZO BIOCHEM INC.
EPICS THERAPEUTICS
EUROFINS SCIENTIFIC
INTERAX BIOTECH AG
MERCK KGAA
ORION BIOTECHNOLOGY CANADA LTD.
PROMEGA CORP.
QIAGEN
REVVITY
TECTONIC THERAPEUTIC
THERMO FISHER SCIENTIFIC INC.
WUXI APPTEC



List of Figures


Summary Figure : Global Market Shares for GPCR-Targeting Technologies, by Region, 2023
Figure 1 : Snapshot of the Market Dynamics for GPCR-Targeting Technologies
Figure 2 : Global Market Shares for GPCR-Targeting Technologies, by Assay Type, 2023
Figure 3 : Global Market Shares for GPCR-Targeting Technologies, by Product Type, 2023
Figure 4 : Global Market Shares for GPCR-Targeting Technologies, by Application, 2023
Figure 5 : Global Market Shares for GPCR-Targeting Technologies, by Region, 2023
Figure 6 : North American Market Shares for GPCR-Targeting Technologies, by Country, 2023
Figure 7 : European Market Shares for GPCR-Targeting Technologies, by Country, 2023
Figure 8 : APAC Market Shares for GPCR-Targeting Technologies, by Country, 2023
Figure 9 : ROW Market Shares for GPCR-Targeting Technologies, by Subregion, 2023
Figure 10 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2023
Figure 11 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2023
Figure 12 : BD: Revenue Share, by Business Unit, FY 2024
Figure 13 : BD: Revenue Share, by Country/Region, FY 2024
Figure 14 : Danaher Corp.: Revenue Share, by Business Unit, FY 2023
Figure 15 : Danaher Corp.: Revenue Share, by Country/Region, FY 2023
Figure 16 : Enzo Biochem Inc.: Revenue Share, by Country/Region, FY 2023
Figure 17 : Eurofins Scientific: Revenue Share, by Business Unit, FY 2023
Figure 18 : Eurofins Scientific: Revenue Share, by Country/Region, FY 2023
Figure 19 : Merck KGaA: Revenue Share, by Business Unit, FY 2023
Figure 20 : Merck KGaA: Revenue Share, by Country/Region, FY 2023
Figure 21 : Qiagen: Revenue Share, by Business Unit, FY 2023
Figure 22 : Qiagen: Revenue Share, by Country/Region, FY 2023
Figure 23 : Revvity: Revenue Share, by Business Unit, FY 2023
Figure 24 : Revvity: Revenue Share, by Country/Region, FY 2023
Figure 25 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, 2023
Figure 26 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, 2023
Figure 27 : Wuxi AppTec: Revenue Share, by Business Unit, 2023
Figure 28 : Wuxi AppTec: Revenue Share, by Country/Region, 2023

List of Tables


Summary Table : Global Market for GPCR-Targeting Technologies, by Region, Through 2029
Table 1 : Number of New Cases and Deaths Due to Various Cancers, Globally, 2022
Table 2 : U.S. NIH Funding for Various Diseases and Conditions, 2019–2023
Table 3 : FDA-Approved Drugs Targeting GPCR, 2020–2024
Table 4 : Patents Issued for GPCRs, by Applicant, January 2023–December 2024
Table 5 : Global Market for GPCR-Targeting Technologies, Through 2029
Table 6 : Global Market for GPCR Targeting Technologies, by Assay Type, Through 2029
Table 7 : Global Market for GPCR-Targeting Technologies, by Product Type, Through 2029
Table 8 : Global Market for GPCR-Targeting Technologies, by Application, Through 2029
Table 9 : GPCRs, Ligands and Their Locations in the Body
Table 10 : GPCR Families and Their Role in CNS Disorders
Table 11 : Glucocorticoid Effects Mediated by Transactivation Mechanisms in Airway Structural Cells
Table 12 : Global Market for GPCR-Targeting Technologies, by Region, Through 2029
Table 13 : North American Market for GPCR-Targeting Technologies, by Country, Through 2029
Table 14 : European Market for GPCR-Targeting Technologies, by Country, Through 2029
Table 15 : APAC Market for GPCR-Targeting Technologies, by Country, Through 2029
Table 16 : ROW Market for GPCR-Targeting Technologies, by Subregion, Through 2029
Table 17 : Market Rankings of Leading Companies in the GPCR-Targeting Technologies Industry, 2023
Table 18 : Funding for GPCR-Targeting Technologies Companies, 2022-2024
Table 19 : ESG Rankings for Major GPCR Companies, 2024*
Table 20 : Sources Used in this Report
Table 21 : Abbreviations Used in this Report
Table 22 : Agilent Technologies Inc.: Company Snapshot
Table 23 : Agilent Technologies Inc.: Financial Performance, FY 2022 and 2023
Table 24 : Agilent Technologies Inc.: Product Portfolio
Table 25 : BD: Company Snapshot
Table 26 : BD: Financial Performance, FY 2023 and 2024
Table 27 : BD: Product Portfolio
Table 28 : Danaher Corp.: Company Snapshot
Table 29 : Danaher Corp.: Financial Performance, FY 2022 and 2023
Table 30 : Danaher Corp.: Product Portfolio
Table 31 : Enzo Biochem Inc.: Company Snapshot
Table 32 : Enzo Biochem Inc.: Financial Performance, FY 2023 and 2024
Table 33 : Enzo Biochem Inc.: Product Portfolio
Table 34 : Epics Therapeutics: Company Snapshot
Table 35 : Epics Therapeutics: Product Portfolio
Table 36 : Eurofins Scientific: Company Snapshot
Table 37 : Eurofins Scientific: Financial Performance, FY 2022 and 2023
Table 38 : Eurofins Scientific: Product Portfolio
Table 39 : InterAx Biotech AG: Company Snapshot
Table 40 : InterAx Biotech AG: Product Portfolio
Table 41 : Merck KGaA: Company Snapshot
Table 42 : Merck KGaA: Financial Performance, FY 2022 and 2023
Table 43 : Merck KGaA: Product Portfolio
Table 44 : Orion Biotechnology Canada Ltd.: Company Snapshot
Table 45 : Orion Biotechnology Canada Ltd.: Product Portfolio
Table 46 : Promega Corp.: Company Snapshot
Table 47 : Promega Corp.: Product Portfolio
Table 48 : Promega Corp.: News/Key Developments, 2023 and 2024
Table 49 : Qiagen: Company Snapshot
Table 50 : Qiagen: Financial Performance, FY 2022 and 2023
Table 51 : Qiagen: Product Portfolio
Table 52 : Revvity: Company Snapshot
Table 53 : Revvity: Financial Performance, FY 2022 and 2023
Table 54 : Revvity: Product Portfolio
Table 55 : Revvity: News/Key Developments, 2021
Table 56 : Tectonic Therapeutic: Company Snapshot
Table 57 : Tectonic Therapeutic: Product Portfolio
Table 58 : Tectonic Therapeutic: News/Key Developments, 2024
Table 59 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 60 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
Table 61 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 62 : Wuxi AppTec: Company Snapshot
Table 63 : Wuxi AppTec: Financial Performance, FY 2022 and 2023
Table 64 : Wuxi AppTec: Product Portfolio